Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Oct 27, 2023; 15(10): 2142-2153
Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2142
Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2142
Outcomes | R-NOSES I-F (n = 22) | RLRC (n = 76) | Ρ value |
Postoperative chemotherapy | 0.995 | ||
XELOX | 7 (31.8) | 24 (31.6) | |
Fluorouracil monotherapy | 3 (13.6) | 11 (14.5) | |
Defecation and urination function scores | |||
Wexner | 4.9 ± 2.6 | 5.2 ± 3.1 | 0.817 |
LARS | 15.3 ± 9.1 | 12.8 ± 10.1 | 0.177 |
IPSS | 3.7 ± 4.6 | 3.5 ± 2.9 | 0.255 |
Status at last follow-up | 0.291 | ||
Local recurrence | 1 (4.5) | 0 | |
Liver metastasis | 0 | 4 (5.3) | |
Lung metastasis | 0 | 3 (3.9) | |
Pelvic metastasis | 0 | 2 (2.6) | |
Dead | 0 | 2 (2.6) |
- Citation: Tao F, Liu DN, He PH, Luo X, Xu CY, Li TY, Duan JY. Robotic natural orifice specimen extraction surgery I-type F method vs conventional robotic resection for lower rectal cancer. World J Gastrointest Surg 2023; 15(10): 2142-2153
- URL: https://www.wjgnet.com/1948-9366/full/v15/i10/2142.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i10.2142